1. Home
  2. List
Reference Patent

Reference - List

  • 20 Hits
  • Search Condition : Filter (MeSH = Immunotherapy*)
Species Resource Title
Human and Animal Cells MBT-2(RCB0544) Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models.
Human and Animal Cells LM8(RCB1450) Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
DNA material pMFGmGM-CSF (RDB01438) , pMFGmIL2 (RDB01441) , pMFGmIL3 (RDB01442) , pMFGmIL4 (RDB01443) , pMFGmIL6 (RDB01444) , pMFGmIL7 (RDB01445) , pMFGmTNF alpha (RDB01449) , pMFGmLT (RDB01451) , pMFGmG-CSF (RDB01452) , pMFGmLIF (RDB01456) Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
Human and Animal Cells NUGC-4(RCB1939) , GSU(RCB2278) Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway.
Human and Animal Cells THP-1(RCB1189) , LLC(RCB0558) Zn- and Mg- containing tricalcium phosphates-based adjuvants for cancer immunotherapy.
Human and Animal Cells Colon-26(RCB2657) Th Balance-Related Host Genetic Background Affects the Therapeutic Effects of Combining Carbon-Ion Radiation Therapy With Dendritic Cell Immunotherapy.
Human and Animal Cells II-18(RCB2093) A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer.
Human and Animal Cells EL4(RCB1641) Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand.
Human and Animal Cells MCF7(RCB1904) Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer.
Human and Animal Cells HEV0060 , PC-9(RCB4455) Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
Human and Animal Cells PC-9(RCB4455) Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy.
Human and Animal Cells LM8(RCB1450) The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma.
General Microbes JCM 31944 Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein.
Human and Animal Cells LLC(RCB0558) Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy.
Human and Animal Cells HSC-3(RCB1975) , HSC-4(RCB1902) Effect of the antibody immunotherapy by the anti-MUC1 monoclonal antibody to the oral squamous cell carcinoma in vitro.
Human and Animal Cells YAC-1(RCB1165) Administration of interleukin-12 and -18 enhancing the antitumor immunity of genetically modified dendritic cells that had been pulsed with Semliki forest virus-mediated tumor complementary DNA.
Human and Animal Cells PC-14(RCB0446) , A549(RCB0098) , LC-2/ad(RCB0440) , LCAM1(RCB1425) , LK-2(RCB1970) , RERF-LC-AI(RCB0444) , EBC-1(RCB1965) , LU65(RCB1967) , Lu99(RCB1900) Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer.
Human and Animal Cells Colon-26(RCB2657) , PC-3(RCB2145) , LLC(RCB0558) The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy.
DNA material , Human and Animal Cells CSII-EF-RfA (RDB04387) , CACO-2(RCB0988) , T2(RCB1932) The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy.
DNA material , Human and Animal Cells CSII-CMV-RfA (RDB04386) , CSII-EF-RfA (RDB04387) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) , T2(RCB1932) Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.